Nautilus, Inc. Reports Fiscal First Quarter 2023 Results
Company Achieves Upper End Q1 Fiscal 2023 Revenue Guidance and Beats Adjusted EBITDA Guidance Direct…
News
Veritone Reports Second Quarter 2022 Results
– Q2 Revenue Up 78% Year Over Year – – Q2 Software and Managed Services…
Supermicro Announces Fourth Quarter and Full Year Fiscal Year 2022 Financial Results
SAN JOSE, Calif.–(BUSINESS WIRE)–Super Micro Computer, Inc. (Nasdaq: SMCI), a global leader in high-performance, high-efficiency…
Revance Reports Second Quarter 2022 Financial Results, Provides Corporate Update
PDUFA date of September 8, 2022 for DaxibotulinumtoxinA for Injection in glabellar lines Reinspection of…
Ontrak Announces 2022 Second Quarter Financial Results
Q2 Revenue of $3.9 million Company pays off in full its $19.2 million outstanding loan…
Comscore Reports Second Quarter 2022 Results
Revenue of $91.4 million, up 4.3% from Q2 2021 Net loss of $5.1 million versus…
Bone Therapeutics to broaden and derisk therapeutic portfolio by acquiring majority participation in Medsenic
INSIDE INFORMATION The acquisition will result in the business combination of Bone Therapeutics and Medsenic…
Taysha Gene Therapies to Release Second Quarter 2022 Financial Results and Host Conference Call and Webcast on August 11
DALLAS, Aug. 09, 2022 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric,…
Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results
SAN DIEGO, Aug. 09, 2022 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology…
Lowell Farms Inc. Announces Unaudited Second Quarter 2022 Financial and Operational Results
SALINAS, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) — Lowell Farms Inc. (the “Company”) (CSE: LOWL;…
Catalyst Pharmaceuticals Delivers Strong Second Quarter 2022 Financial Results with Record FIRDAPSE® Revenues and Provides Corporate Update
Achieved Record Q2 2022 FIRDAPSE® Net Product Revenues of $53.0 Million, a 57.7% YoY Increase…
Quoin Pharmaceuticals Announces Closing of $16.8 Million Public Offering
ASHBURN, Va., Aug. 09, 2022 (GLOBE NEWSWIRE) — Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company”…
Verona Pharma plc Announces Proposed Underwritten Public Offering
LONDON and RALEIGH, N.C., Aug. 09, 2022 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA)…
Certara Reports Second Quarter 2022 Financial Results
Biosimulation software and services fuel second quarter growth PRINCETON, N.J., Aug. 09, 2022 (GLOBE NEWSWIRE)…
Vaccitech Reports Second Quarter 2022 Financial Results and Recent Corporate Developments
OXFORD, United Kingdom, Aug. 09, 2022 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC) today announced…
Idera Pharmaceuticals Reports Second Quarter 2022 Financial Results
EXTON, Pa., Aug. 09, 2022 (GLOBE NEWSWIRE) — Idera Pharmaceuticals, Inc. (“Idera,” the “Company,” “we,”…
Celularity Reports Second Quarter 2022 Financial Results and Corporate Update
– Announced first patient treated in Phase 1/2a clinical trial for CYNK-101 in first-line advanced…
Codex DNA Reports Second Quarter 2022 Financial Results
SAN DIEGO, Aug. 09, 2022 (GLOBE NEWSWIRE) — Codex DNA, Inc. (Nasdaq: DNAY), a pioneer…
Organogenesis Holdings Inc. Reports Second Quarter 2022 Financial Results
CANTON, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading…
Assembly Biosciences Reports Second Quarter 2022 Financial Results and Recent Highlights
SOUTH SAN FRANCISCO, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB),…